Asymptomatic Carotid Surgery Trial 2
ACST-2 is a world-wide stroke prevention study comparing carotid endarterectomy (CEA) versus carotid artery stenting (CAS) in patients with asymptomatic carotid stenosis where there is substantial uncertainty as to which treatment is more appropriate.
- It addresses an important scientific question comparing the two procedures in stroke prevention with long term follow up of at least 5 years.
- The trial is sponsored & managed by the University of Oxford (the number one ranked University in the world for medicine), and supported by the world renowned Clinical Trial Service Unit (CTSU).
- ACST-2 is a large international trial with experienced collaborators from over 26 countries from around the world. It is the largest investigator led asymptomatic carotid intervention study in the world!
We aim to randomise several thousand patients to enable a meaningful comparison between surgery and stenting.
ACST-2 is Funded by ....
ACST-2 is the Biggest ....
ACST-2 ... Is now the biggest investigator-led asymptomatic carotid intervention study (CEA vs CAS) in the world well done!BUT ..We need to randomise lots more patients, our monthly target as a collaborative group is 40